Articles

Quick View: Launch Of Critical Medicines Alliance Will Mitigate Drug Shortages And Promote Local Pharmaceutical Production In The EU

Pharmaceuticals / Europe / Fri 19 Jan, 2024

The Latest: On January 16 2024, the European Commission’s Health Emergency Preparedness and Response Authority launched an open call for expression of interest to join the Critical Medicines Alliance (CMA). This represents the first major step towards the founding of the alliance which is planned to address drug shortages at the EU level. In

Read More

Quick View: Lupin Achieves Three New Generic Approvals In The US Highlighting Continued Interest In Expanding Generics Portfolio

Pharmaceuticals / United States / Thu 18 Jan, 2024

The Latest: On January 14 2024, Lupin announced that it had received US FDA approval to market a generic version of propranolol hydrochloride extended-release capsules, used in the treatment of migraine and hypertension. The approval is significant as Lupin can offer a more affordable alternative to ANI Pharmaceuticals' Inderal LA extended

Read More

Singapore Not Likely To See Another Bumper Year For FDI

Country Risk / Singapore / Thu 18 Jan, 2024

Key View

  • We expect inward FDI to fall below 30% of GDP in 2023 and 2024.
  • A jump in retained earnings were behind the FDI increase in 2021 and 2022, and they notably did little to boost economic growth in Singapore.
  • The expected reduction in inward FDI will not pose risks to Singapore’s external balance, given ample foreign reserves and
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.